Trials / Completed
CompletedNCT00701285
South Korean Pitavastatin Heart Failure Study
A Prospective, Randomized, Two Group Comparison Study to Evaluate the Effect of Statin on Heart Function in Patients With Chronic Ischemic Heart Failure.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- JW Pharmaceutical · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
We want to evaluate the utility of statins on heart function according to potency. Patients with chronic ischemic heart failure are administered pitavastatin 4mg or pravastatin 10mg for 52 weeks. Then we evaluate the effect of pitavastatin and pravastatin primarily on rate of hospitalization for cardiovascular cause and lipid profile secondarily biomarker, echocardiography parameter, 6-minute walk, change of NYHA class distribution, cardiovascular mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pitavastatin | pitavastatin 4mg once daily |
| DRUG | pravastatin | pravastatin 10mg once daily |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2013-05-01
- Completion
- 2014-05-01
- First posted
- 2008-06-19
- Last updated
- 2014-05-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00701285. Inclusion in this directory is not an endorsement.